CPSI - TBRG Forward P/S Multiple

Corporate emblem and logo of TruBridge, Inc. (TBRG)

TruBridge, Inc. (TBRG) is a reliable partner for US municipal hospitals, streamlining healthcare administration. The forward price-to-sales valuation illustrates the trend of market expectations, where the current parameter stands at 0.10. The transition to cloud subscriptions scales business margins, while the use of external developers alongside in-house billing and strict SLAs minimizes the company's operational risks.

TruBridge Inc - TBRG Market Cap to Future Revenue Ratio (period 03/05/2024 - 07/25/2026)

Analytical breakdowns for TruBridge, Inc.

- current price and projected stock value:
Fundamental company valuation:TruBridge TBRG
Product sample of TruBridge, Inc.

This ratio reflects the market value of the business relative to expected revenue, allowing for a real-time assessment of whether the asset is undervalued or overpriced. Analyzing the forward P/S multiple helps evaluate the effectiveness of TruBridge, Inc. (TBRG) B2B subscriptions within the rural clinic segment, where the stability of revenue from billing automation directly impacts the investment attractiveness and fair value of the company's shares.

Competitors of TruBridge, Inc. (TBRG)

Forward P/S Multiple VEEV (Veeva)|DOCS: Market Cap to Projected Revenue|HealthEquity Corp - Forward P/S Multiple|Projected Price to Revenue Waystar Corp (WAY)|CRVL: Forward P/S Multiple|Market Cap to Future Revenue Ratio priviahealth.com (PRVA)|Forward Price-to-Revenue Multiple HURN|CERT: Forward Price to Sales|Forward P/S Multiple OMCL|Market Cap to Expected Sales Ratio GoodRx Gold|Price-to-Projected Revenue Ratio Schrodinger, Inc. SDGR|PHR: Market Cap to Projected Revenue|Omada Health - Forward P/S Multiple|Evolent Health Inc (EVH) - Forward Price-to-Revenue Multiple|HSTM (HealthStream Corp) - Forward Price-to-Revenue Multiple|DH - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple CCSI|AGL (agilonhealth.com) - Price to Expected Revenue Ratio|Forward P/S Multiple ABSI|Price-to-Projected Revenue Ratio SY (So-Young International Inc)|Price-to-Projected Revenue Ratio National Research Corporation NRC|Forward Price to Sales SPOK|OptimizeRx Corporation - Forward P/S Multiple|Projected Price to Revenue simulations-plus.com (SLP)|SOPH: Forward P/S Multiple|HCAT - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple CCLD|RSSS (Research Solutions Inc.) - Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple DLHC (DLH Holdings Corp.)|ONMD (onemednet.com) - Forward Price to Sales|Price-to-Projected Revenue Ratio Scienture SCNX|HCTI - Forward Price-to-Revenue Multiple|iSpecimen Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Bullfrog AI Holdings|WORX: Forward P/S Multiple|Market Cap to Projected Revenue MSPR|Forward Price-to-Revenue Multiple ICCT|MEDS (TRxADE HEALTH Inc) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio Orgenesis Corp (ORGS)|RCM (r1rcm.com) - Forward Price to Sales|Sharecare, Inc. - Forward Price-to-Revenue Multiple|Forward P/S Multiple streamlinehealth.net STRM|Syra Health - Forward P/S Multiple|AMEH: Price-to-Projected Revenue Ratio|Model N Corp (MODN) - Price-to-Projected Revenue Ratio|NextGen Healthcare Corp - Forward Price to Sales